ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

MRI-based Quantification of Intratumoral Heterogeneity for Predicting Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer

Shi, Zhenwei; Huang, Xiaomei; Cheng, Ziliang; Xu, Zeyan; Lin, Huan; Liu, Chen; Chen, Xiaobo; Liu, Chunling; Liang, Changhong; Lu, Cheng; Cui, Yanfen; Han, Chu; Qu, Jinrong; Shen, Jun; Liu, Zaiyi*广东省人民医院; 广东省心血管病研究所; 南方医科大学; 郑州大学; 中山大学
RADIOLOGY2023-7DOI: 10.1148/radiol.222830
5被引5阅读
引用收藏
分享

摘要

Background: Breast cancer is highly heterogeneous, resulting in different treatment responses to neoadjuvant chemotherapy (NAC) among patients. A noninvasive quantitative measure of intratumoral heterogeneity (ITH) may be valuable for predicting treatment response. @@@ Purpose: To develop a quantitative measure of ITH on pretreatment MRI scans and test its performance for predicting pathologic complete response (pCR) after NAC in patients with breast cancer. @@@ Materials and Methods: Pretreatment MRI scans were retrospectively acquired in patients with breast cancer who received NAC followed by surgery at multiple centers from January 2000 to September 2020. Conventional radiomics (hereafter, C-radiomics) and intratumoral ecological diversity features were extracted from the MRI scans, and output probabilities of imaging-based decision tree models were used to generate a C-radiomics score and ITH index. Multivariable logistic regression analysis was used to identify variables associated with pCR, and significant variables, including clinicopathologic variables, C-radiomics score, and ITH index, were combined into a predictive model for which performance was assessed using the area under the receiver operating characteristic curve (AUC). @@@ Results: The training data set was comprised of 335 patients (median age, 48 years [IQR, 42-54 years]) from centers A and B, and 590, 280, and 384 patients (median age, 48 years [IQR, 41-55 years]) were included in the three external test data sets. Molecular subtype (odds ratio [OR] range, 4.76-8.39 [95% CI: 1.79, 24.21]; all P < .01), ITH index (OR, 30.05 [95% CI: 8.43, 122.64]; P < .001), and C-radiomics score (OR, 29.90 [95% CI: 12.04, 81.70]; P < .001) were independently associated with the odds of achieving pCR. The combined model showed good performance for predicting pCR to NAC in the training data set (AUC, 0.90) and external test data sets (AUC range, 0.83-0.87). @@@ Conclusion: A model that combined an index created from pretreatment MRI-based imaging features quantitating ITH, C-radiomics score, and clinicopathologic variables showed good performance for predicting pCR to NAC in patients with breast cancer. Published under a CC BY 4.0 license.

相关
加载中…
  • Radiomics Based on DCE-MRI for Predicting Response to Neoadjuvant Therapy in Breast Cancer
    Zeng, Qiao; Xiong, Fei; Liu, Lan; Zhong, Linhua; Cai, Fengqin; Zeng, Xianjun*ACADEMIC RADIOLOGY, 2023, 30 Suppl 2: S38-S49.
  • MRI-based Quantification of Intratumoral Heterogeneity for Predicting Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer (vol 308, e222830, 2023)
    Shi, Zhenwei*; Huang, Xiaomei; Cheng, Ziliang; Xu, Zeyan; Lin, Huan; Liu, Chen; Chen, Xiaobo; Liu, Chunling; Liang, Changhong; Lu, Cheng; Cui, Yanfen; Han, Chu; Qu, Jinrong; Shen, Jun; Li, ZaiyiRADIOLOGY, 2023, 308(1): e239021.
  • Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study
    Huang, YuHong; Zhu, Teng; Zhang, XiaoLing; Li, Wei; Zheng, XingXing; Cheng, MinYi; Ji, Fei; Zhang, LiuLu; Yang, CiQiu; Wu, ZhiYong*; Ye, GuoLin*; Lin, Ying*; Wang, Kun*ECLINICALMEDICINE, 2023, 58.被引 14
查看全部 →

发表信息

论文状态
公开发表
期刊
RADIOLOGY
发表日期
2023-07
卷期
第 308 卷, 第 1 期
页码
e222830
DOI
10.1148/radiol.222830
语言
ENGLISH
成果收录
SCIE
资助标注
Key-Area Research and Development Program of Guangdong Province [2021B0101420006]; Regional Innovation and Development Joint Fund of National Natural Science Foundation of China [U22A20345]; National Key Research and Development Program of China [2021YFF1201003]; National Science Fund for Distinguished Young Scholars [81925023]; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application [2022B1212010011]; National Natural Science Foundation of China [82102034, 62102103, 82001789, 82171920, 12126610, 82171996, U1801681]; China Postdoctoral Science Foundation [2022M710843, 2021M700897]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2017); Natural Science Foundation for Distinguished Young Scholars of Guangdong Province [2023B1515020043]; Guangdong Laboratory of Artificial Intelligence and Digital Economy [GML-KF-22-30]

作者

  • S

    Shi, Zhenwei (第一作者)

    guangdong prov peoples hosp · southern med univ · guangdong cardiovasc inst

  • H

    Huang, Xiaomei

    southern med univ

查看全部 15 位作者收起作者
  • C

    Cheng, Ziliang

    sun yat sen univ

  • X

    Xu, Zeyan

    guangdong prov peoples hosp · southern med univ

  • L

    Lin, Huan

    guangdong prov peoples hosp · southern med univ

  • L

    Liu, Chen

    guangdong prov peoples hosp · southern med univ · 2

  • C

    Chen, Xiaobo

    guangdong prov peoples hosp · southern med univ · 2

  • L

    Liu, Chunling

    guangdong prov peoples hosp · southern med univ

  • L

    Liang, Changhong

    guangdong prov peoples hosp · southern med univ

  • L

    Lu, Cheng

    guangdong prov peoples hosp · southern med univ

  • C

    Cui, Yanfen

    shanxi canc hosp · shanxi med univ · guangdong prov peoples hosp · southern med univ · guangdong cardiovasc inst

  • H

    Han, Chu

    guangdong prov peoples hosp · southern med univ

  • Q

    Qu, Jinrong

    zhengzhou univ

  • S

    Shen, Jun

    sun yat sen univ

  • L

    Liu, Zaiyi (通讯)

    guangdong prov peoples hosp · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417